Spero Therapeutics (SPRO) Asset Writedowns and Impairment (2023 - 2025)
Spero Therapeutics (SPRO) recorded Asset Writedowns and Impairment of $587,000 in FY2025.
Powered by 
Analysis
Spero Therapeutics (SPRO) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends
- Annual Asset Writedowns and Impairment has a three-year compound annual growth rate of -2.6% (FY2022 to FY2025).
- Per Business Quant data, SPRO's Asset Writedowns and Impairment was $5.31 million in FY2023 (+735.6%) and $635,000 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.00 Bn | 1,106.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.40 Bn | 554.26 Bn | 17.30 Bn |
| 3 | AbbVie | 506.36 Bn | 479.47 Bn | 12.70 Bn |
| 4 | Merck | 358.30 Bn | 312.68 Bn | 12.21 Bn |
| 5 | Novartis Ag | 293.12 Bn | 257.11 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.36 Bn | 239.05 Bn | 12.86 Bn |
| 7 | Amgen | 238.40 Bn | 193.80 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.15 Bn | 169.35 Bn | 6.22 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn |
| 10 | Spero Therapeutics | 64.29 Mn | -131.49 Mn | - |
API Access
Spero Therapeutics Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();